Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production
- PMID: 975058
Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production
Abstract
Cultured mouse blastocysts produce plasminogen activator, a protease that converts the zymogen plasminogen into the trypsin-like enzyme, plasmin. We have fractionated the blastocyst and cultured the constituent cell types. Trophoblast outgrowths free of inner cell mass derivatives secrete plasminogen activator during a time period that closely parallels the invasive phase of trophoblast cells in utero. Isolated inner cell masses also produce plasminogen activator; further fractionation of the inner cell mass as well as studies with primary cultures obtained from midgestation tissues demonstrate that enzyme formation is restricted entirely to parietal endoderm cells. Secretion of the enzyme may facilitate the migration of parietal endoderm cells along the trophoblast layer as the yolk sac cavity enlarges during gestation. F9 embryonal carcinoma cells do not secrete detectable amounts of plasminogen activator. However, when these cells are induced to differentiate, the resulting parietal endoderm-like cells are capable of producing the enzyme. These results are consistent with previous findings suggesting that plasminogen activator production may be a characteristic of invasive and/or migratory cells.
Similar articles
-
Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm.Cell. 1976 Oct;9(2):231-40. doi: 10.1016/0092-8674(76)90114-8. Cell. 1976. PMID: 975245
-
In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.Cancer Res. 1976 Nov;36(11 Pt. 2):4217-23. Cancer Res. 1976. PMID: 184930
-
TGF-beta 1 regulation of laminin secretion by F9-derived primitive endoderm cells: a potential role in cell migration within the mouse blastocyst.Can J Physiol Pharmacol. 1996 Aug;74(8):940-8. Can J Physiol Pharmacol. 1996. PMID: 8960384
-
In vitro development of inner cell masses isolated immunosurgically from mouse blastocysts. II. Inner cell masses from 3.5- to 4.0-day p.c. blastocysts.J Embryol Exp Morphol. 1978 Jun;45:107-21. J Embryol Exp Morphol. 1978. PMID: 353213
-
Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.Biken J. 1984 Dec;27(4):143-51. Biken J. 1984. PMID: 6443174
Cited by
-
Regulation and patterns of endogenous and exogenous gene expression during differentiation of embryonal carcinoma cells.Environ Health Perspect. 1989 Mar;80:25-38. doi: 10.1289/ehp.898025. Environ Health Perspect. 1989. PMID: 2564340 Free PMC article. Review.
-
Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.Proc Natl Acad Sci U S A. 1978 Feb;75(2):750-3. doi: 10.1073/pnas.75.2.750. Proc Natl Acad Sci U S A. 1978. PMID: 204931 Free PMC article.
-
Plasminogen activator in cultured Lewis lung carcinoma cells measured by chromogenic substrate assay.Br J Cancer. 1980 Aug;42(2):305-13. doi: 10.1038/bjc.1980.231. Br J Cancer. 1980. PMID: 7191713 Free PMC article.
-
Modulation of granule cell migration by a glia-derived protein.Proc Natl Acad Sci U S A. 1986 Jun;83(12):4568-71. doi: 10.1073/pnas.83.12.4568. Proc Natl Acad Sci U S A. 1986. PMID: 3459192 Free PMC article.
-
[The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].Mund Kiefer Gesichtschir. 2004 May;8(3):173-9. doi: 10.1007/s10006-003-0520-x. Epub 2004 Feb 6. Mund Kiefer Gesichtschir. 2004. PMID: 15138855 German.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous